MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

Search

Integra LifeSciences Holdings Corp

Ouvert

SecteurSoins de santé

16.33 -1.27

Résumé

Variation du prix de l'action

24h

Actuel

Min

16.14

Max

16.91

Chiffres clés

By Trading Economics

Revenu

30M

19M

Ventes

62M

443M

P/E

Moyenne du Secteur

63.02

57.333

BPA

0.97

Marge bénéficiaire

4.391

Employés

4,396

EBITDA

40M

79M

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+47.31% upside

Dividendes

By Dow Jones

Prochains Résultats

5 mai 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-819M

1.2B

Ouverture précédente

17.6

Clôture précédente

16.33

Score Technique

By Trading Central

Confiance

Strong Bullish Evidence

Integra LifeSciences Holdings Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

6 mai 2024, 16:47 UTC

Résultats
Principaux Mouvements du Marché

Integra LifeSciences Shares Drop to Record Low on Unexpected Loss, Boston Facility Audit Findings

Comparaison

Variation de prix

Integra LifeSciences Holdings Corp prévision

Objectif de Prix

By TipRanks

47.31% hausse

Prévisions sur 12 Mois

Moyen 24.6 USD  47.31%

Haut 35 USD

Bas 19 USD

Basé sur 6 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

6 ratings

2

Achat

2

Maintien

2

Vente

Score Technique

By Trading Central

15.67 / 17.29Support & Résistance

Court Terme

Strong Bullish Evidence

Moyen Terme

Very Strong Bearish Evidence

Long Terme

Bearish Evidence

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Integra LifeSciences Holdings Corp

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.